Literature DB >> 25970720

Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan.

Hans Maier, Karlheinz Hehemann, Michael Vieth.   

Abstract

An 83-year-old woman with hypertension received the angiotensin-II receptor type 1 blocker (ARB) eprosartan for more than 10 years. Six months ago, the dosage of the drug was doubled, and the patient reported a sudden onset of diarrhea. Duodenal biopsies showed a celiac disease-like pathology with flattened mucosa and an increase of intraepithelial lymphocytes and eosinophils, but serology of celiac disease remained negative. Celiac disease-like changes have been previously reported to be associated with other ARBs. This is the first case following eprosartan medication. In celiac-disease-like pathology of the small bowel with negative serology, drug-induced changes, for example due to ARBs, should be excluded.

Entities:  

Keywords:  celiac disease - negative serology - ARB - eprosartan.

Mesh:

Substances:

Year:  2015        PMID: 25970720

Source DB:  PubMed          Journal:  Cesk Patol        ISSN: 1210-7875


  7 in total

Review 1.  Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Authors:  René R Wenzel; Christian Datz
Journal:  Wien Klin Wochenschr       Date:  2019-08-30       Impact factor: 1.704

2.  Angiotensin Receptor Blockers Associated Enteropathy-Brief Report.

Authors:  Neha Gosai; Falgun Gosai
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-05-02

3.  Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome.

Authors:  Takanori Uehara; Masatomi Ikusaka; Yoshiyuki Ohira; Kazutaka Noda; Shingo Suzuki; Kiyoshi Shikino; Takeshi Kondo; Hideki Kajiwara; Akiko Ikegami; Yusuke Hirota
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271

Review 4.  Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.

Authors:  Ayesha Kamal; Christopher Fain; Angela Park; Peiqi Wang; Eduardo Gonzalez-Velez; Daniel A Leffler; Susan M Hutfless
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-01

5.  Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Authors:  Harshal Surendra Mandavdhare; Vishal Sharma; Kaushal K Prasad; Amit Kumar; Manish Rathi; Surinder S Rana
Journal:  Intest Res       Date:  2017-06-12

6.  Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.

Authors:  Peter Malfertheiner; Claudio Ripellino; Nazarena Cataldo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-19       Impact factor: 2.890

7.  Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.

Authors:  Neil O'Morain; Eileen Shannon; John McManus; Vanessa Warner; Hilary Leeson; Helen O'Donovan; Brian Egan; Valerie Byrnes
Journal:  United European Gastroenterol J       Date:  2021-06-29       Impact factor: 4.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.